home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

CHIPing Away at Cancer Metastasis

 
  February, 18 2009 8:12
your information resource in human molecular genetics
 
     

Scientists have uncovered that an enzyme called CHIP suppresses breast cancer. The research, online in Nature Cell Biology, suggests that a target of the enzyme known as SRC-3 represents a promising new molecular target for this cancer.

Many solid tumours form metastases, where the cancer spreads from its site of origin -- this is the main reason for therapeutic failure and cancer mortality. As such, there is a renewed focus on designing drugs that target molecular pathways required for metastasis.

Junn Yanagisawa and colleagues report that CHIP, which is known to degrade a number of cancer causing proteins, also acts to degrade the gene regulator SRC-3, which then suppresses tumour progression in breast cancer. In a mouse model, CHIP expression inhibited metastasis formation, while its deletion accelerated the process. Loss of CHIP leads to increased expression of a number of cancer associated proteins, causing cells to become invasive and to grow in an uncontrolled manner, both attributes of cancer cells.

Since SRC-3 accounts for the cancer suppressive role of CHIP, it presents a new therapeutic target for breast cancer.

Author contact:

Junn Yanagisawa (University of Tsukuba, Japan)
E-mail: junny@agbi.tsukuba.ac.jp

Abstract available online.

(C) Nature Cell Biology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.